Cynata Therapeutics Limited (ASX:CYP)
Australia · Delayed Price · Currency is AUD 0.3750
+0.0150 (4.17%)
Apr 20, 2026, 3:58 PM AEST
Cynata Therapeutics Market Cap
Cynata Therapeutics has a market cap or net worth of 86.67 million as of April 20, 2026. Its market cap has increased by 113.10% in one year.
Market Cap
86.67M
Enterprise Value
84.08M
Revenue
1.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.38
Market Cap Chart
Since December 20, 2007, Cynata Therapeutics's market cap has increased from 15.60M to 86.67M, an increase of 455.73%. That is a compound annual growth rate of 9.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 85.48M | 4.35% |
| Dec 31, 2025 | 81.92M | 51.54% |
| Dec 31, 2024 | 54.06M | 140.75% |
| Dec 29, 2023 | 22.45M | -47.76% |
| Dec 30, 2022 | 42.98M | -44.95% |
| Dec 31, 2021 | 78.09M | -17.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 108.75M |
| Island Pharmaceuticals | 106.41M |
| Immutep | 101.69M |
| Paradigm Biopharmaceuticals | 101.65M |
| Arovella Therapeutics | 97.91M |
| Botanix Pharmaceuticals | 97.57M |
| Amplia Therapeutics | 84.66M |
| LTR Pharma | 72.71M |